Proesis Biologics, Inc. is a pioneering biotech startup from the United States, established in 2022. The company's slogan, "Plasma for the Future. Rewards for Life.", encapsulates its mission to revolutionize the plasma donation process. Proesis Bio's innovative human source plasma collection platform aims to enhance the plasma donation journey, benefiting all stakeholders. Operating in the Biotechnology and Health Care industries, the company collaborates with communities and donors to provide the industry with high-quality plasma essential for treating individuals with rare and chronic conditions worldwide. Overall, Proesis Biologics, Inc. presents a futuristic approach to plasma collection, aligning with the growing demand for advanced biotechnology solutions in healthcare. As a potential investment opportunity, Proesis Bio's emphasis on scalability and its dedication to improving the plasma donation journey position it as a promising venture for socially responsible and forward-thinking investors in the healthcare and biotech sectors.
There is no investment information
No recent news or press coverage available for Proesis Biologics, Inc..